Page last updated: 2024-12-08
ar-l 57 cl
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
AR-L 57 CL: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 173795 |
SCHEMBL ID | 11769751 |
MeSH ID | M0059804 |
Synonyms (16)
Synonym |
---|
ar-l-57-cl |
ar-l 57 cl |
ar-l-57 cl |
ar-l57 |
61393-38-2 |
ar-l 57 |
SCHEMBL11769751 |
DTXSID90210313 |
2-(2,4-dimethoxyphenyl)-imidazo-[4,5-b]-pyridine hydrochloride |
2-(2,4-dimethoxyphenyl)-1h-imidazo[4,5-b]pyridine;hydrochloride |
AKOS040750572 |
1h-imidazo[4,5-b]pyridine, 2-(2,4-dimethoxyphenyl)-, monohydrochloride |
2-(2,4-dimethoxyphenyl)-3h-imidazo[5,4-b]pyridine hydrochloride |
53929-89-8 |
YVG4V8KQ7X |
3h-imidazo[4,5-b]pyridine, 2-(2,4-dimethoxyphenyl)-, hydrochloride (1:1) |
Research Excerpts
Pharmacokinetics
Excerpt | Reference | Relevance |
---|---|---|
" The decrease in plasma concentration could be expressed in terms of an open two-compartment pharmacokinetic model." | ( Investigation of the pharmacodynamics and pharmacokinetics of 2-(2,4-dimethoxyphenyl)-Imidazo-(4,5-b)-pyridine hydrochloride (AR-L 57 CL) in man. Belz, GG; Nübling, H; Zimmer, A, 1976) | 0.46 |
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" By contrast, carbachol did not alter the dose-response profile to AR-L57." | ( A comparison of the cardiotonic effects of AR-L115 and AR-L57: evidence for distinct inotropic mechanisms. Hayes, JS; Pollock, GD; Wilson, H; Wyss, VL, ) | 0.13 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.81
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.81) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (8.33%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (91.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |